Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 34.87% Upside Potential in the Railroads Sector 25 November 2025
Chemring Group PLC (CHG.L) Stock Analysis: Aerospace & Defense Leader with 31.94% Upside Potential 25 November 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Engineering Giant with 16.4% Revenue Growth and Strong Market Position 25 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 34.87% Upside Potential in the Railroads Sector 25 November 2025
Chemring Group PLC (CHG.L) Stock Analysis: Aerospace & Defense Leader with 31.94% Upside Potential 25 November 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Engineering Giant with 16.4% Revenue Growth and Strong Market Position 25 November 2025
Delcath Systems, Inc. (DCTH) Stock Analysis: A High-Potential Opportunity with Over 132% Upside 15 August 2025
Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 223.97% Potential Upside in Biotech Innovation 15 August 2025
Castle Biosciences, Inc. (CSTL) Stock Analysis: A Diagnostic Powerhouse with 79.74% Potential Upside 15 August 2025
KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Exploring a 144% Upside Potential in Biotech 15 August 2025
Definitive Healthcare Corp. (DH) Stock Analysis: Navigating a 19.41% Potential Upside in Healthcare Information Services 15 August 2025
Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 127.96% Upside Potential in the Healthcare Sector 15 August 2025
SI-BONE, Inc. (SIBN) Stock Analysis: A Medical Device Innovator with 63% Upside Potential 15 August 2025
Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with 84% Upside Potential 15 August 2025
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Potential 292% Upside in the Biotech Sector 15 August 2025
Immunome, Inc. (IMNM) Stock Analysis: A 143.96% Potential Upside in the Biotech Sector 15 August 2025
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A Promising 18.95% Upside with Strong Buy Ratings 15 August 2025
AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 65.87% Potential Upside in the Healthcare Sector 15 August 2025
OrthoPediatrics Corp. (KIDS) Stock Analysis: A Closer Look at the 76.98% Potential Upside 15 August 2025
Owens & Minor, Inc. (OMI) Stock Analysis: Evaluating the 16% Upside Potential Amidst Challenging Metrics 15 August 2025
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Visionary Biotech with a 24% Upside Potential 15 August 2025
CeriBell, Inc. (CBLL) Stock Analysis: Unpacking a 154% Potential Upside for this Medical Device Innovator 15 August 2025
Nutex Health Inc. (NUTX) Stock Analysis: A Healthcare Growth Star with 123% Potential Upside 15 August 2025
Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a Potential 185.71% Upside in the Biotech Sector 15 August 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video) 10 September 2025
Scottish Mortgage Investment Trust reports 22.9% NAV growth for six months to September 2025 7 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 34.87% Upside Potential in the Railroads Sector 25 November 2025
Chemring Group PLC (CHG.L) Stock Analysis: Aerospace & Defense Leader with 31.94% Upside Potential 25 November 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Engineering Giant with 16.4% Revenue Growth and Strong Market Position 25 November 2025
